The Market Reports
Call: +1-631-407-1315 / +91-750-729-1479
Email: sales@themarketreports.com
Prostate Cancer Treatment Drugs-Global Market Insights and Sales Trends 2024
Synopsis
Adoption of innovative technologies in screening & diagnostic tests is projected to drive growth. The incorporation of multiparametric MRI (mp-MRI) can significantly improve the detection of tumor and also provide confirmation whether there is a need for tissue biopsy. In addition, market players are investing in research for the development of therapeutic products for the treatment of such tumors. For instance, there is a strong pipeline of products such as Tc-99m (Progenics), radium-223 dichloride (Xofigo, Bayer), ODM-201 (Orion and Bayer), which are in their phase 3 studies and are projected to enter the market in the near future. In addition, many generic products are likely to enter the market owing to the expiry of patents of the major existing products during the forecast period. Thus, these factors are expected to drive growth.
The global Prostate Cancer Treatment Drugs market size is expected to reach US$ 18760 million by 2029, growing at a CAGR of 4.0% from 2023 to 2029. The market is mainly driven by the significant applications of Prostate Cancer Treatment Drugs in various end use industries. The expanding demands from the Hospitals, Ambulatory Surgical Centers and Clinics,, are propelling Prostate Cancer Treatment Drugs market. Zytiga, one of the segments analysed in this report, is projected to record % CAGR and reach US$ million by the end of the analysis period. Growth in the Gonax segment is estimated at % CAGR for the next seven-year period.
The global pharmaceutical market is 1475 billion USD in 2022, growing at a CAGR of 5% during the next six years. The pharmaceutical market includes chemical drugs and biological drugs. For biologics is expected to 381 billion USD in 2022. In comparison, the chemical drug market is estimated to increase from 1005 billion in 2018 to 1094 billion U.S. dollars in 2022. The pharmaceutical market factors such as increasing demand for healthcare, technological advancements, and the rising prevalence of chronic diseases, increase in funding from private & government organizations for development of pharmaceutical manufacturing segments and rise in R&D activities for drugs. However, the industry also faces challenges such as stringent regulations, high costs of research and development, and patent expirations. Companies need to continuously innovate and adapt to these challenges to stay competitive in the market and ensure their products reach patients in need. Additionally, the COVID-19 pandemic has highlighted the importance of vaccine development and supply chain management, further emphasizing the need for pharmaceutical companies to be agile and responsive to emerging public health needs.
Report Objectives
This report provides market insight on the different segments, by players, by Type, by Application. Market size and forecast (2018-2029) has been provided in the report. The primary objectives of this report are to provide 1) global market size and forecasts, growth rates, market dynamics, industry structure and developments, market situation, trends; 2) global market share and ranking by company; 3) comprehensive presentation of the global market for Prostate Cancer Treatment Drugs, with both quantitative and qualitative analysis through detailed segmentation; 4) detailed value chain analysis and review of growth factors essential for the existing market players and new entrants; 5) emerging opportunities in the market and the future impact of major drivers and restraints of the market.
Key Features of The Study:
This report provides in-depth analysis of the global Prostate Cancer Treatment Drugs market, and provides market size (US$ million) and CAGR for the forecast period (2023-2029), considering 2022 as the base year.
This report profiles key players in the global Prostate Cancer Treatment Drugs market based on the following parameters - company details (found date, headquarters, manufacturing bases), products portfolio, Prostate Cancer Treatment Drugs sales data, market share and ranking.
This report elucidates potential market opportunities across different segments and explains attractive investment proposition matrices for this market.
This report illustrates key insights about market drivers, restraints, opportunities, market trends, regional outlook.
Key companies of Prostate Cancer Treatment Drugs covered in this report include Johnson & Johnson, Astella, Sanofi, Ipsen, Bayer, AstraZeneca and Dendreon, etc.
The global Prostate Cancer Treatment Drugs market report caters to various stakeholders in this industry including investors, suppliers, product players, distributors, new entrants, and financial analysts.
Market Segmentation
Company Profiles:
Johnson & Johnson
Astella
Sanofi
Ipsen
Bayer
AstraZeneca
Dendreon
Global Prostate Cancer Treatment Drugs market, by region:
North America (U.S., Canada, Mexico)
Europe (Germany, France, UK, Italy, etc.)
Asia Pacific (China, Japan, South Korea, Southeast Asia, India, etc.)
South America (Brazil, etc.)
Middle East and Africa (Turkey, GCC Countries, Africa, etc.)
Global Prostate Cancer Treatment Drugs market, Segment by Type:
Zytiga
Gonax
Lupron
Zoladex
Decapeptyl
Eligard
Vantas
Casodex
Others
Global Prostate Cancer Treatment Drugs market, by Application
Hospitals
Ambulatory Surgical Centers
Clinics
Core Chapters
Chapter One: Introduces the report scope of the report, executive summary of global and regional market size and CAGR for the history and forecast period (2018-2023, 2024-2029). It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter Two: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter Three: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter Four: Detailed analysis of Prostate Cancer Treatment Drugs companies’ competitive landscape, revenue, market share and ranking, latest development plan, merger, and acquisition information, etc.
Chapter Five: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product introduction, revenue, recent development, etc.
Chapter Six, Seven, Eight, Nine and Ten: North America, Europe, Asia Pacific, Latin America, Middle East & Africa, revenue by country.
Chapter Eleven: this section also introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by companies in the industry, and the analysis of relevant policies in the industry.
Chapter Twelve: Research Finding/Conclusion
Adoption of innovative technologies in screening & diagnostic tests is projected to drive growth. The incorporation of multiparametric MRI (mp-MRI) can significantly improve the detection of tumor and also provide confirmation whether there is a need for tissue biopsy. In addition, market players are investing in research for the development of therapeutic products for the treatment of such tumors. For instance, there is a strong pipeline of products such as Tc-99m (Progenics), radium-223 dichloride (Xofigo, Bayer), ODM-201 (Orion and Bayer), which are in their phase 3 studies and are projected to enter the market in the near future. In addition, many generic products are likely to enter the market owing to the expiry of patents of the major existing products during the forecast period. Thus, these factors are expected to drive growth.
The global Prostate Cancer Treatment Drugs market size is expected to reach US$ 18760 million by 2029, growing at a CAGR of 4.0% from 2023 to 2029. The market is mainly driven by the significant applications of Prostate Cancer Treatment Drugs in various end use industries. The expanding demands from the Hospitals, Ambulatory Surgical Centers and Clinics,, are propelling Prostate Cancer Treatment Drugs market. Zytiga, one of the segments analysed in this report, is projected to record % CAGR and reach US$ million by the end of the analysis period. Growth in the Gonax segment is estimated at % CAGR for the next seven-year period.
The global pharmaceutical market is 1475 billion USD in 2022, growing at a CAGR of 5% during the next six years. The pharmaceutical market includes chemical drugs and biological drugs. For biologics is expected to 381 billion USD in 2022. In comparison, the chemical drug market is estimated to increase from 1005 billion in 2018 to 1094 billion U.S. dollars in 2022. The pharmaceutical market factors such as increasing demand for healthcare, technological advancements, and the rising prevalence of chronic diseases, increase in funding from private & government organizations for development of pharmaceutical manufacturing segments and rise in R&D activities for drugs. However, the industry also faces challenges such as stringent regulations, high costs of research and development, and patent expirations. Companies need to continuously innovate and adapt to these challenges to stay competitive in the market and ensure their products reach patients in need. Additionally, the COVID-19 pandemic has highlighted the importance of vaccine development and supply chain management, further emphasizing the need for pharmaceutical companies to be agile and responsive to emerging public health needs.
Report Objectives
This report provides market insight on the different segments, by players, by Type, by Application. Market size and forecast (2018-2029) has been provided in the report. The primary objectives of this report are to provide 1) global market size and forecasts, growth rates, market dynamics, industry structure and developments, market situation, trends; 2) global market share and ranking by company; 3) comprehensive presentation of the global market for Prostate Cancer Treatment Drugs, with both quantitative and qualitative analysis through detailed segmentation; 4) detailed value chain analysis and review of growth factors essential for the existing market players and new entrants; 5) emerging opportunities in the market and the future impact of major drivers and restraints of the market.
Key Features of The Study:
This report provides in-depth analysis of the global Prostate Cancer Treatment Drugs market, and provides market size (US$ million) and CAGR for the forecast period (2023-2029), considering 2022 as the base year.
This report profiles key players in the global Prostate Cancer Treatment Drugs market based on the following parameters - company details (found date, headquarters, manufacturing bases), products portfolio, Prostate Cancer Treatment Drugs sales data, market share and ranking.
This report elucidates potential market opportunities across different segments and explains attractive investment proposition matrices for this market.
This report illustrates key insights about market drivers, restraints, opportunities, market trends, regional outlook.
Key companies of Prostate Cancer Treatment Drugs covered in this report include Johnson & Johnson, Astella, Sanofi, Ipsen, Bayer, AstraZeneca and Dendreon, etc.
The global Prostate Cancer Treatment Drugs market report caters to various stakeholders in this industry including investors, suppliers, product players, distributors, new entrants, and financial analysts.
Market Segmentation
Company Profiles:
Johnson & Johnson
Astella
Sanofi
Ipsen
Bayer
AstraZeneca
Dendreon
Global Prostate Cancer Treatment Drugs market, by region:
North America (U.S., Canada, Mexico)
Europe (Germany, France, UK, Italy, etc.)
Asia Pacific (China, Japan, South Korea, Southeast Asia, India, etc.)
South America (Brazil, etc.)
Middle East and Africa (Turkey, GCC Countries, Africa, etc.)
Global Prostate Cancer Treatment Drugs market, Segment by Type:
Zytiga
Gonax
Lupron
Zoladex
Decapeptyl
Eligard
Vantas
Casodex
Others
Global Prostate Cancer Treatment Drugs market, by Application
Hospitals
Ambulatory Surgical Centers
Clinics
Core Chapters
Chapter One: Introduces the report scope of the report, executive summary of global and regional market size and CAGR for the history and forecast period (2018-2023, 2024-2029). It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter Two: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter Three: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter Four: Detailed analysis of Prostate Cancer Treatment Drugs companies’ competitive landscape, revenue, market share and ranking, latest development plan, merger, and acquisition information, etc.
Chapter Five: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product introduction, revenue, recent development, etc.
Chapter Six, Seven, Eight, Nine and Ten: North America, Europe, Asia Pacific, Latin America, Middle East & Africa, revenue by country.
Chapter Eleven: this section also introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by companies in the industry, and the analysis of relevant policies in the industry.
Chapter Twelve: Research Finding/Conclusion
Index1 Market Overview of Prostate Cancer Treatment Drugs
1.1 Prostate Cancer Treatment Drugs Market Overview
1.1.1 Prostate Cancer Treatment Drugs Product Scope
1.1.2 Prostate Cancer Treatment Drugs Market Status and Outlook
1.2 Global Prostate Cancer Treatment Drugs Market Size Overview by Region 2018 VS 2022 VS 2029
1.3 Global Prostate Cancer Treatment Drugs Market Size by Region (2018-2029)
1.4 Global Prostate Cancer Treatment Drugs Historic Market Size by Region (2018-2023)
1.5 Global Prostate Cancer Treatment Drugs Market Size Forecast by Region (2024-2029)
1.6 Key Regions, Prostate Cancer Treatment Drugs Market Size (2018-2029)
1.6.1 North America Prostate Cancer Treatment Drugs Market Size (2018-2029)
1.6.2 Europe Prostate Cancer Treatment Drugs Market Size (2018-2029)
1.6.3 Asia-Pacific Prostate Cancer Treatment Drugs Market Size (2018-2029)
1.6.4 Latin America Prostate Cancer Treatment Drugs Market Size (2018-2029)
1.6.5 Middle East & Africa Prostate Cancer Treatment Drugs Market Size (2018-2029)
2 Prostate Cancer Treatment Drugs Market by Type
2.1 Introduction
2.1.1 Zytiga
2.1.2 Gonax
2.1.3 Lupron
2.1.4 Zoladex
2.1.5 Decapeptyl
2.1.6 Eligard
2.1.7 Vantas
2.1.8 Casodex
2.1.9 Others
2.2 Global Prostate Cancer Treatment Drugs Market Size by Type: 2018 VS 2022 VS 2029
2.2.1 Global Prostate Cancer Treatment Drugs Historic Market Size by Type (2018-2023)
2.2.2 Global Prostate Cancer Treatment Drugs Forecasted Market Size by Type (2024-2029)
2.3 Key Regions Market Size by Type
2.3.1 North America Prostate Cancer Treatment Drugs Revenue Breakdown by Type (2018-2029)
2.3.2 Europe Prostate Cancer Treatment Drugs Revenue Breakdown by Type (2018-2029)
2.3.3 Asia-Pacific Prostate Cancer Treatment Drugs Revenue Breakdown by Type (2018-2029)
2.3.4 Latin America Prostate Cancer Treatment Drugs Revenue Breakdown by Type (2018-2029)
2.3.5 Middle East and Africa Prostate Cancer Treatment Drugs Revenue Breakdown by Type (2018-2029)
3 Prostate Cancer Treatment Drugs Market Overview by Application
3.1 Introduction
3.1.1 Hospitals
3.1.2 Ambulatory Surgical Centers
3.1.3 Clinics
3.2 Global Prostate Cancer Treatment Drugs Market Size by Application: 2018 VS 2022 VS 2029
3.2.1 Global Prostate Cancer Treatment Drugs Historic Market Size by Application (2018-2023)
3.2.2 Global Prostate Cancer Treatment Drugs Forecasted Market Size by Application (2024-2029)
3.3 Key Regions Market Size by Application
3.3.1 North America Prostate Cancer Treatment Drugs Revenue Breakdown by Application (2018-2029)
3.3.2 Europe Prostate Cancer Treatment Drugs Revenue Breakdown by Application (2018-2029)
3.3.3 Asia-Pacific Prostate Cancer Treatment Drugs Revenue Breakdown by Application (2018-2029)
3.3.4 Latin America Prostate Cancer Treatment Drugs Revenue Breakdown by Application (2018-2029)
3.3.5 Middle East and Africa Prostate Cancer Treatment Drugs Revenue Breakdown by Application (2018-2029)
4 Prostate Cancer Treatment Drugs Competition Analysis by Players
4.1 Global Prostate Cancer Treatment Drugs Market Size by Players (2018-2023)
4.2 Global Top Players by Company Type (Tier 1, Tier 2 and Tier 3) & (based on the Revenue in Prostate Cancer Treatment Drugs as of 2022)
4.3 Date of Key Players Enter into Prostate Cancer Treatment Drugs Market
4.4 Global Top Players Prostate Cancer Treatment Drugs Headquarters and Area Served
4.5 Key Players Prostate Cancer Treatment Drugs Product Solution and Service
4.6 Competitive Status
4.6.1 Prostate Cancer Treatment Drugs Market Concentration Rate
4.6.2 Mergers & Acquisitions, Expansion Plans
5 Company (Top Players) Profiles
5.1 Johnson & Johnson
5.1.1 Johnson & Johnson Profile
5.1.2 Johnson & Johnson Main Business
5.1.3 Johnson & Johnson Prostate Cancer Treatment Drugs Products, Services and Solutions
5.1.4 Johnson & Johnson Prostate Cancer Treatment Drugs Revenue (US$ Million) & (2018-2023)
5.1.5 Johnson & Johnson Recent Developments
5.2 Astella
5.2.1 Astella Profile
5.2.2 Astella Main Business
5.2.3 Astella Prostate Cancer Treatment Drugs Products, Services and Solutions
5.2.4 Astella Prostate Cancer Treatment Drugs Revenue (US$ Million) & (2018-2023)
5.2.5 Astella Recent Developments
5.3 Sanofi
5.3.1 Sanofi Profile
5.3.2 Sanofi Main Business
5.3.3 Sanofi Prostate Cancer Treatment Drugs Products, Services and Solutions
5.3.4 Sanofi Prostate Cancer Treatment Drugs Revenue (US$ Million) & (2018-2023)
5.3.5 Ipsen Recent Developments
5.4 Ipsen
5.4.1 Ipsen Profile
5.4.2 Ipsen Main Business
5.4.3 Ipsen Prostate Cancer Treatment Drugs Products, Services and Solutions
5.4.4 Ipsen Prostate Cancer Treatment Drugs Revenue (US$ Million) & (2018-2023)
5.4.5 Ipsen Recent Developments
5.5 Bayer
5.5.1 Bayer Profile
5.5.2 Bayer Main Business
5.5.3 Bayer Prostate Cancer Treatment Drugs Products, Services and Solutions
5.5.4 Bayer Prostate Cancer Treatment Drugs Revenue (US$ Million) & (2018-2023)
5.5.5 Bayer Recent Developments
5.6 AstraZeneca
5.6.1 AstraZeneca Profile
5.6.2 AstraZeneca Main Business
5.6.3 AstraZeneca Prostate Cancer Treatment Drugs Products, Services and Solutions
5.6.4 AstraZeneca Prostate Cancer Treatment Drugs Revenue (US$ Million) & (2018-2023)
5.6.5 AstraZeneca Recent Developments
5.7 Dendreon
5.7.1 Dendreon Profile
5.7.2 Dendreon Main Business
5.7.3 Dendreon Prostate Cancer Treatment Drugs Products, Services and Solutions
5.7.4 Dendreon Prostate Cancer Treatment Drugs Revenue (US$ Million) & (2018-2023)
5.7.5 Dendreon Recent Developments
6 North America
6.1 North America Prostate Cancer Treatment Drugs Market Size by Country (2018-2029)
6.2 U.S.
6.3 Canada
7 Europe
7.1 Europe Prostate Cancer Treatment Drugs Market Size by Country (2018-2029)
7.2 Germany
7.3 France
7.4 U.K.
7.5 Italy
7.6 Russia
7.7 Nordic Countries
7.8 Rest of Europe
8 Asia-Pacific
8.1 Asia-Pacific Prostate Cancer Treatment Drugs Market Size by Region (2018-2029)
8.2 China
8.3 Japan
8.4 South Korea
8.5 Southeast Asia
8.6 India
8.7 Australia
8.8 Rest of Asia-Pacific
9 Latin America
9.1 Latin America Prostate Cancer Treatment Drugs Market Size by Country (2018-2029)
9.2 Mexico
9.3 Brazil
9.4 Rest of Latin America
10 Middle East & Africa
10.1 Middle East & Africa Prostate Cancer Treatment Drugs Market Size by Country (2018-2029)
10.2 Turkey
10.3 Saudi Arabia
10.4 UAE
10.5 Rest of Middle East & Africa
11 Prostate Cancer Treatment Drugs Market Dynamics
11.1 Prostate Cancer Treatment Drugs Industry Trends
11.2 Prostate Cancer Treatment Drugs Market Drivers
11.3 Prostate Cancer Treatment Drugs Market Challenges
11.4 Prostate Cancer Treatment Drugs Market Restraints
12 Research Finding /Conclusion
13 Methodology and Data Source
13.1 Methodology/Research Approach
13.1.1 Research Programs/Design
13.1.2 Market Size Estimation
13.1.3 Market Breakdown and Data Triangulation
13.2 Data Source
13.2.1 Secondary Sources
13.2.2 Primary Sources
13.3 Disclaimer
13.4 Author List
Published By : QY Research
Why ‘The Market Reports’
In Business:
Pre Sales Support:
Post Sales Support:
Turn Around Time:
Clients Served:
Clients Assisted:
Client Types:
Payment:
- Accept global payments [Credit Card / PayPal / Wire Transfer]
- Accept local payments in South Korea, Germany, China and India [Can pay in local currency]
Latest Life Science Market Reports
Payments Accepted From
Connect with us at
Complete Secure Website
